Cargando…

Impact of changing the measles vaccine vial size on Niger's vaccine supply chain: a computational model

BACKGROUND: Many countries, such as Niger, are considering changing their vaccine vial size presentation and may want to evaluate the subsequent impact on their supply chains, the series of steps required to get vaccines from their manufacturers to patients. The measles vaccine is particularly impor...

Descripción completa

Detalles Bibliográficos
Autores principales: Assi, Tina-Marie, Brown, Shawn T, Djibo, Ali, Norman, Bryan A, Rajgopal, Jayant, Welling, Joel S, Chen, Sheng-I, Bailey, Rachel R, Kone, Souleymane, Kenea, Hailu, Connor, Diana L, Wateska, Angela R, Jana, Anirban, Wisniewski, Stephen R, Van Panhuis, Willem G, Burke, Donald S, Lee, Bruce Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3129313/
https://www.ncbi.nlm.nih.gov/pubmed/21635774
http://dx.doi.org/10.1186/1471-2458-11-425
_version_ 1782207532222119936
author Assi, Tina-Marie
Brown, Shawn T
Djibo, Ali
Norman, Bryan A
Rajgopal, Jayant
Welling, Joel S
Chen, Sheng-I
Bailey, Rachel R
Kone, Souleymane
Kenea, Hailu
Connor, Diana L
Wateska, Angela R
Jana, Anirban
Wisniewski, Stephen R
Van Panhuis, Willem G
Burke, Donald S
Lee, Bruce Y
author_facet Assi, Tina-Marie
Brown, Shawn T
Djibo, Ali
Norman, Bryan A
Rajgopal, Jayant
Welling, Joel S
Chen, Sheng-I
Bailey, Rachel R
Kone, Souleymane
Kenea, Hailu
Connor, Diana L
Wateska, Angela R
Jana, Anirban
Wisniewski, Stephen R
Van Panhuis, Willem G
Burke, Donald S
Lee, Bruce Y
author_sort Assi, Tina-Marie
collection PubMed
description BACKGROUND: Many countries, such as Niger, are considering changing their vaccine vial size presentation and may want to evaluate the subsequent impact on their supply chains, the series of steps required to get vaccines from their manufacturers to patients. The measles vaccine is particularly important in Niger, a country prone to measles outbreaks. METHODS: We developed a detailed discrete event simulation model of the vaccine supply chain representing every vaccine, storage location, refrigerator, freezer, and transport device (e.g., cold trucks, 4 × 4 trucks, and vaccine carriers) in the Niger Expanded Programme on Immunization (EPI). Experiments simulated the impact of replacing the 10-dose measles vial size with 5-dose, 2-dose and 1-dose vial sizes. RESULTS: Switching from the 10-dose to the 5-dose, 2-dose and 1-dose vial sizes decreased the average availability of EPI vaccines for arriving patients from 83% to 82%, 81% and 78%, respectively for a 100% target population size. The switches also changed transport vehicle's utilization from a mean of 58% (range: 4-164%) to means of 59% (range: 4-164%), 62% (range: 4-175%), and 67% (range: 5-192%), respectively, between the regional and district stores, and from a mean of 160% (range: 83-300%) to means of 161% (range: 82-322%), 175% (range: 78-344%), and 198% (range: 88-402%), respectively, between the district to integrated health centres (IHC). The switch also changed district level storage utilization from a mean of 65% to means of 64%, 66% and 68% (range for all scenarios: 3-100%). Finally, accounting for vaccine administration, wastage, and disposal, replacing the 10-dose vial with the 5 or 1-dose vials would increase the cost per immunized patient from $0.47US to $0.71US and $1.26US, respectively. CONCLUSIONS: The switch from the 10-dose measles vaccines to smaller vial sizes could overwhelm the capacities of many storage facilities and transport vehicles as well as increase the cost per vaccinated child.
format Online
Article
Text
id pubmed-3129313
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31293132011-07-05 Impact of changing the measles vaccine vial size on Niger's vaccine supply chain: a computational model Assi, Tina-Marie Brown, Shawn T Djibo, Ali Norman, Bryan A Rajgopal, Jayant Welling, Joel S Chen, Sheng-I Bailey, Rachel R Kone, Souleymane Kenea, Hailu Connor, Diana L Wateska, Angela R Jana, Anirban Wisniewski, Stephen R Van Panhuis, Willem G Burke, Donald S Lee, Bruce Y BMC Public Health Research Article BACKGROUND: Many countries, such as Niger, are considering changing their vaccine vial size presentation and may want to evaluate the subsequent impact on their supply chains, the series of steps required to get vaccines from their manufacturers to patients. The measles vaccine is particularly important in Niger, a country prone to measles outbreaks. METHODS: We developed a detailed discrete event simulation model of the vaccine supply chain representing every vaccine, storage location, refrigerator, freezer, and transport device (e.g., cold trucks, 4 × 4 trucks, and vaccine carriers) in the Niger Expanded Programme on Immunization (EPI). Experiments simulated the impact of replacing the 10-dose measles vial size with 5-dose, 2-dose and 1-dose vial sizes. RESULTS: Switching from the 10-dose to the 5-dose, 2-dose and 1-dose vial sizes decreased the average availability of EPI vaccines for arriving patients from 83% to 82%, 81% and 78%, respectively for a 100% target population size. The switches also changed transport vehicle's utilization from a mean of 58% (range: 4-164%) to means of 59% (range: 4-164%), 62% (range: 4-175%), and 67% (range: 5-192%), respectively, between the regional and district stores, and from a mean of 160% (range: 83-300%) to means of 161% (range: 82-322%), 175% (range: 78-344%), and 198% (range: 88-402%), respectively, between the district to integrated health centres (IHC). The switch also changed district level storage utilization from a mean of 65% to means of 64%, 66% and 68% (range for all scenarios: 3-100%). Finally, accounting for vaccine administration, wastage, and disposal, replacing the 10-dose vial with the 5 or 1-dose vials would increase the cost per immunized patient from $0.47US to $0.71US and $1.26US, respectively. CONCLUSIONS: The switch from the 10-dose measles vaccines to smaller vial sizes could overwhelm the capacities of many storage facilities and transport vehicles as well as increase the cost per vaccinated child. BioMed Central 2011-06-02 /pmc/articles/PMC3129313/ /pubmed/21635774 http://dx.doi.org/10.1186/1471-2458-11-425 Text en Copyright ©2011 Assi et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Assi, Tina-Marie
Brown, Shawn T
Djibo, Ali
Norman, Bryan A
Rajgopal, Jayant
Welling, Joel S
Chen, Sheng-I
Bailey, Rachel R
Kone, Souleymane
Kenea, Hailu
Connor, Diana L
Wateska, Angela R
Jana, Anirban
Wisniewski, Stephen R
Van Panhuis, Willem G
Burke, Donald S
Lee, Bruce Y
Impact of changing the measles vaccine vial size on Niger's vaccine supply chain: a computational model
title Impact of changing the measles vaccine vial size on Niger's vaccine supply chain: a computational model
title_full Impact of changing the measles vaccine vial size on Niger's vaccine supply chain: a computational model
title_fullStr Impact of changing the measles vaccine vial size on Niger's vaccine supply chain: a computational model
title_full_unstemmed Impact of changing the measles vaccine vial size on Niger's vaccine supply chain: a computational model
title_short Impact of changing the measles vaccine vial size on Niger's vaccine supply chain: a computational model
title_sort impact of changing the measles vaccine vial size on niger's vaccine supply chain: a computational model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3129313/
https://www.ncbi.nlm.nih.gov/pubmed/21635774
http://dx.doi.org/10.1186/1471-2458-11-425
work_keys_str_mv AT assitinamarie impactofchangingthemeaslesvaccinevialsizeonnigersvaccinesupplychainacomputationalmodel
AT brownshawnt impactofchangingthemeaslesvaccinevialsizeonnigersvaccinesupplychainacomputationalmodel
AT djiboali impactofchangingthemeaslesvaccinevialsizeonnigersvaccinesupplychainacomputationalmodel
AT normanbryana impactofchangingthemeaslesvaccinevialsizeonnigersvaccinesupplychainacomputationalmodel
AT rajgopaljayant impactofchangingthemeaslesvaccinevialsizeonnigersvaccinesupplychainacomputationalmodel
AT wellingjoels impactofchangingthemeaslesvaccinevialsizeonnigersvaccinesupplychainacomputationalmodel
AT chenshengi impactofchangingthemeaslesvaccinevialsizeonnigersvaccinesupplychainacomputationalmodel
AT baileyrachelr impactofchangingthemeaslesvaccinevialsizeonnigersvaccinesupplychainacomputationalmodel
AT konesouleymane impactofchangingthemeaslesvaccinevialsizeonnigersvaccinesupplychainacomputationalmodel
AT keneahailu impactofchangingthemeaslesvaccinevialsizeonnigersvaccinesupplychainacomputationalmodel
AT connordianal impactofchangingthemeaslesvaccinevialsizeonnigersvaccinesupplychainacomputationalmodel
AT wateskaangelar impactofchangingthemeaslesvaccinevialsizeonnigersvaccinesupplychainacomputationalmodel
AT janaanirban impactofchangingthemeaslesvaccinevialsizeonnigersvaccinesupplychainacomputationalmodel
AT wisniewskistephenr impactofchangingthemeaslesvaccinevialsizeonnigersvaccinesupplychainacomputationalmodel
AT vanpanhuiswillemg impactofchangingthemeaslesvaccinevialsizeonnigersvaccinesupplychainacomputationalmodel
AT burkedonalds impactofchangingthemeaslesvaccinevialsizeonnigersvaccinesupplychainacomputationalmodel
AT leebrucey impactofchangingthemeaslesvaccinevialsizeonnigersvaccinesupplychainacomputationalmodel